An inactive form of renin has been found in human and animal blood, kidneys, brain, and amniotic fluid. This inactive renin increases renin activity in vitro upon exposure to acid pH 3.3 followed by alkaline pH 7.4, low temperature, the proteases trypsin and pepsin, and urinary kallikrein. The purpose of this study is to show the effects of angiotensin 11 and saralasin on inactive renin and renin in five fetal lambs 120-130 days gestation, and five lambs.115-138 days, using the chronic sheep preparation. Inactive renin (after cryoactivation and trypsin activation) and renin, after generation of angiotensin 1 are measured by radioimmunoassay. Cryorenin and trypsin activated renin decreased from 4.0 + 1.0 ng/ml/hr of plasma renin activity (PRA) (M and SEM) and 7.3-& 1.0 to 0.05 2 0.01 and 1.7 2 1.0 (pC.01) respectivly, after 15 min of angiotensin 11 infusion (0.25 ug/kg/ min); renin did not statistically decrease. Cryoactivated and trypsin activated renin increased from 2.2 2 0.5 ng/ml/hr and 4.9 + 0.9 of PRA to 4.6 21.0 and 8.5 + 1.5, respectively after 30 min (p<.05) of the saralasin (10 ugJkg/min) infusion, while renin showed no change. Furosemide increased inactive renin in parallel to renin. In conclusion: 1) angiotensin 11 can inhibit inactive renin, but not renin; 2) a negative feedback loop exists between angiotensin 11 and inactive renin, but not renin; and 3) trypsin activates inactive renin more effectively than cryoactivation; in the fetal lamb.
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EXAMPLE OF THE EFFICACY OF PREDNISONE IN THE CONTROL OF TYPE I MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS.
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~ontroversy.exiBts as t o the u t i l i t y o f brednisone i n the treatment o f membranoproliferative glomerulonephritis (MPGN). Two patients w i t h Type I disease were treated a t the onset o f t h e i r disease w i t h 2 mg/kg/day o f prednisone i n divided doses f o r 2 weeks and then maintained on every-other-day therapy i n decreasing doses f o r 4 & 6 years. I n the f i r s t month, serumlevels o f C3 and f a c t o r B became normal and C3NeF disappeared. I n the f i r s t 2 years, c r e a t i n i n e clearances increased from 40 & 51 t o 95 & 100 cc/min; p r o t e i n u r i a decreased from 8 and 11 t o 0.5 and 0.75 grams124 hrs; and t o t a l serum proteins rose from 4.4 & 4.1 t o 6.8 and 7.8 g%. I n i t i a l l y , edema was minimized w i t h l a s i x therapy while blood pressure was c o n t r o l l e d w i t h the a i d o f hydralazine, aldomet, and propranolol . A f t e r 3 & 4 years, a l l medications except prednisone were withdrawn without change i n c l i n i c a l o r laboratory findings. A f t e r 4 & 6 years, prednisone therapy was tapered and discontinued. Within 30 and 60 days, C3 and f a c t o r B l e v e l s decreased by 50%, C3NeF returned, creatinine clearances decreased by 44%, p r o t e i n u r i a increased t o 4 and 4.5 9/24 hrs, and blood pressure rose t o l e v e l s greater than the 95th p e r c e n t i l e f o r age. Prednisone was r e i n s t i t u t e d on a d a i l y schedule; i n 3 months, a l l findings returned t o "near normal" again. These data suggest t h a t prednisone was important i n cont r o l l i n g the a c t i v i t y o f MPGN i n these 2 patients. The possibil i t y t h a t both patients had spontaneous remissions and relapses coincident w i t h the changes i n prednisone i s u n l i k e l y . HUS i s an important cause o f acute renal f a i l u r e i n c h i l d r e n and i t s pathogenesis remains unknown. Recently i t has been suggested t h a t i n both HUS and Thrombotic Thrombocytopenic Purpura there i s a defect o f an endogenous i n h i b i t o r o f p l a t e l e t aggregation, prostacyclin. The i n f u s i o n o f plasma has been reported t o be an e f f e c t i v e means o f reversing t h i s defect. Ten consecutive children w i t h HUS, anuric a t the time o f diagnosis and who required peritoneal d i a l y s i s were treated w i t h d a i l y plasma ( 5 ml/kg) f o r a mean o f 7.8 days. Their outcome was compared retrospectively w i t h ten consecutive patients, seen over the previous two years, who were also anuric and required p e r itoneal d i a l y s i s , b u t d i d n o t receive plasma. Recovery from the microangiopathic process, as judged by a r i s i n g p l a t e l e t count, occurred a f t e r 6.5 days i n the plasma treated group and a f t e r 6.6 days i n those n o t given plasma. There were no deaths i n e i t h e r group but one p a t i e n t i n the no plasma group has required long term d i a l y s i s and two patients i n each group have m i l d chronic renal f a i l u r e . Six patients i n the plasma treated group required d i a l y s i s f o r more than 14 days. These r e s u l t s do n o t suggest any beneficial e f f e c t from plasma i n f u s i o n i n anuric The pathogenetic r o l e o f renal hypercalciuria and absorptive hypercalciuria i n children w i t h u r o l i t h i a s i s has not been f u l l y evaluated. Therefore, we examined urine calcium(UCa), c r e a t i n i n e (UCr) and u r i c acid(UUa) excretion a f t e r an overnight f a s t and following o r a l c a l c i u m ( l .~~m / l . 73m2 body surface area) i n 47 normal children and i n 16 children w i t h calcareous renal stones which were n o t secondary t o i n f e c t i o n , immobilization o r obstruct i o n . M i l k products and supplemental vitamins were r e s t r i c t e d f o r 5 days p r i o r t o the study. Urine was c o l l e c t e d f o r 2 hours before and 4 hours a f t e r the calcium load and a standardized breakfast. To assess the role of maturity on the renal responses to asphyxia (Asph)l6 spontaneously born term (T) and 5 preterm (PT)experimental and 12 control (C) lambs were studied between 1-6 days of age. We procured surviving PT lambs by induction of delivery at 133 days gestation with a fetal glucocorticoid injection. Asphyxia was induced by adding 38 ml/kg of dead space to the airway for 20 min. changing the arterial blood pH to 7.05 in the T, 7.17 in the PT, pO2 to 36 in the T and 29 torr in the PT and pCO2 to 66 in the T and 62 torr in the PT groups. The studies continued for 2 hrs. following the removal of the dead space. Plasma glucose concentrations increased significantly (peak:M?SE 285+50m1/ dl) from baseline in the T during and for 15 min. after Asph. Excreted glucose increased and the percentage of tubular reabsorption of glucose decreased significantly (p<0.05), after Asph. Urine volumes, fractional and absolute sodium excretions, and osmolar clearances increased in the PT and T groups during Asph. and significantly (p<0.05) 30 min. after the removal of the dead space. No differences were observed between the PT and T groups when these changes were compared. GFR,total renal blood flow (microsphere technique),and plasma renin values did not change significantly during or after Asph. in either the T or PT groups. Changes were not seen in the C lambs. The data indicate that irrespective of maturity, Asph. produces significant hyperglycemia with concomitant natriuresis and osmotic diuresis. P.H. has been reported as having a good prognosis except in some cases of IgA mesangial deposition (MGN-A) with focal segmental sclerosis and proliferation (FSS) which may progress to ESRD. HLA, lymphocytes bearing surface IgA (SIgA), serum immunoglobulins (Ig) and renal histopathology were evaluated in patients with P.H. persisting>6 months. HLA-A, B and C were determined in 49 patients (29 MGN-A and 20 MGN-non A) and in 524 controls. In P.H. patients the frequency of Bw35 was 43% (similar in MGN-A and MGN-non A) and 23% in controls (p(0.01).
TREATMENT OF THE HEMOLYTIC UREMIC SYNDROME (HUS) WITH
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Dr7 was present in 8/22 MGN-A (36%) but only in 19/109 (17%) control subjects. SIgA was elevated in 41/42 (98%) patients but only in 3/52 (6%) controls (p(0.001).
Mean serum IgA and IgM levels were higher in P.H. patients compared to controls. Of 10 Bw35 patients with MGN-A, 9 had FSS (3 of the 9 evolving to ESRD) compared to 8/19 withoug Bw35 (p (0.01).
It is concluded that 1) HLA-Bw35 is present and SIgA elevated more frequently in patients than in controls, and may be useful in separating P.H. from other hematurias, 2) a positive correlation of these findings with FSS and; or progression to ESRD exists only in MGN-A patients, 3) Dr7 seems increased in MGN-A patients, and 4) some P.H. patients
Hub.
require renal biopsy for better assessment of prognosis.
